TC BIOPHARM HOLDINGS PLC-ADR (TCBP) Forecast, Price Target & Analyst Ratings

NASDAQ:TCBPUS87807D6085

Current stock price

0.5 USD
-1.04 (-67.53%)
At close:
0.6701 USD
+0.17 (+34.02%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for TC BIOPHARM HOLDINGS PLC-ADR (TCBP).

Forecast Snapshot

Consensus Price Target

Price Target
$48.96
+ 9,692.00% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
Dec 13, 2022
Period
Q3 / 2023
EPS Estimate
-£0.81
Revenue Estimate
504.9K

ChartMill Buy Consensus

Rating
82.86%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$48.96
Upside
+ 9,692.00%
From current price of $0.50 to mean target of $48.96, Based on 7 analyst forecasts
Low
$48.48
Median
$48.96
High
$50.40

Price Target Revisions

1 Month
0.00%
3 Months
1,500.00%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for TCBP. The average price target is 48.96 USD. This implies a price increase of 9692% is expected in the next year compared to the current price of 0.5.
The average price target has been revised upward by 1500% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

TCBP Current Analyst RatingTCBP Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

TCBP Historical Analyst RatingsTCBP Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.86%
TCBP was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about TCBP.
In the previous month the buy percentage consensus was at a similar level.
TCBP was analyzed by 7 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2024-12-06HC Wainwright & Co.Maintains Buy -> Buy
2023-04-27HC Wainwright & Co.Maintains Buy
2023-01-26HC Wainwright & Co.Initiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Dec 13, 2022
Period
Q3 / 2023
EPS Estimate
-£0.81
Revenue Estimate
504.9K
Revenue Q2Q
0.00%
EPS Q2Q
99.93%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

TCBP is expected to report earnings on 12/13/2022. The consensus EPS estimate for the next earnings is -0.81 USD and the consensus revenue estimate is 504.90K USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.

Full Analyst Estimates 2024 - 2025

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2020 2021 2022 2023 2024 2025
Revenue
YoY % growth
TCBP revenue by date.TCBP revenue by date.
1.98M
-42.27%
1.98M3.84M
93.94%
2.018M
-100.00%
EBITDA
YoY % growth
TCBP ebitda by date.TCBP ebitda by date.
-5.82M
-2.46%
-6.29M
-8.08%
-10.95M
-74.09%
N/A
-24.26%
N/AN/A
EBIT
YoY % growth
TCBP ebit by date.TCBP ebit by date.
-6.89M
-4.71%
-7.31M
-6.10%
-11.92M
-63.06%
-24.094M
-19.46%
-13.813M
2.99%
-14.484M
-4.86%
Operating Margin
TCBP operating margin by date.TCBP operating margin by date.
-347.98%-369.19%-310.42%-1,193.98%N/AN/A
EPS
YoY % growth
TCBP eps by date.TCBP eps by date.
N/AN/AN/A-4.69
99.99%
-0.16
96.52%
0.00
100.00%

All data in GBP

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 23 Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.81
99.93%
-0.71
99.94%
N/A0.00
100.00%
0.00
100.00%
0.00
100.00%
0.000.000.000.00
Revenue
Q2Q % growth
504.9K504.9K
-86.87%
N/A
-100.00%

-100.00%
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-5.514M
-8.01%
-5.616M
52.89%
N/A-3.366M
56.20%
-3.443M
37.57%
-3.494M
37.80%
-3.545M-3.596M
-6.82%
-3.825M
-11.11%
-3.698M
-5.84%

All data in GBP

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

TCBP Yearly Revenue VS EstimatesTCBP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 1M 2M 3M
TCBP Yearly EPS VS EstimatesTCBP Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 -10K -20K -30K

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

TC BIOPHARM HOLDINGS PLC-ADR / TCBP Forecast FAQ

What is the price target for TCBP stock?

7 analysts have analysed TCBP and the average price target is 48.96 USD. This implies a price increase of 9692% is expected in the next year compared to the current price of 0.5.

What is the next earnings date for TCBP stock?

TC BIOPHARM HOLDINGS PLC-ADR (TCBP) will report earnings on 2022-12-13, before the market open.

What are the consensus estimates for TC BIOPHARM HOLDINGS PLC-ADR (TCBP) next earnings?

The consensus EPS estimate for the next earnings of TC BIOPHARM HOLDINGS PLC-ADR (TCBP) is -0.81 USD and the consensus revenue estimate is 504.90K USD.